US2009043097A1PendingUtilityA1
Methods
Est. expiryDec 5, 2023(expired)· nominal 20-yr term from priority
C07D 513/04C07D 497/04A61P 17/06
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for the preparation of a compound of formula (1) or a pharmaceutically acceptable salt or solvate thereof; from a compound of the formula: (IV); wherein L represents a leaving group.
Claims
exact text as granted — not AI-modified1 - 9 . (canceled)
10 . A compound selected from
5-[[(2,3-difluorophenyl)methyl]thio]-7-[[(1 R)-2-hydroxy-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one, potassium salt; 5-[[(2,3-difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one, sodium salt; and 5-[[(2,3-difluorophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]thiazolo[4,5-d]pyrimidin-2(3H)-one, potassium salt.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.